A clinical prediction model for infusion-related reactions to rituximab in patients with B cell lymphomas
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Clinical Pharmacy"
DOI: 10.1007/s11096-017-0429-3
Abstract: Background Infusion-related reactions (IRRs) are a major adverse event of rituximab. Objective To develop a prediction model for IRRs to rituximab among patients with B cell non- Hodgkin’s lymphomas (B-NHL). Setting A 1000-bed university hospital… read more here.
Keywords: irrs rituximab; rituximab; infusion related; prediction model ... See more keywords
A novel prednisone premedication protocol significantly decreases infusion‑related reactions of rituximab in newly diagnosed diffuse large B‑cell lymphoma
Sign Up to like & getrecommendations! Published in 2023 at "Oncology Letters"
DOI: 10.3892/ol.2023.13844
Abstract: Rituximab is a widely used anti-CD20 monoclonal antibody with a high incidence of infusion-related reactions (IRRs) during administration. Reducing the incidence of IRRs remains problematic in hematological practices. In the present study, a novel strategy… read more here.
Keywords: incidence; group; incidence irrs; irrs rituximab ... See more keywords